Edinburgh Imaging's current dementia projects.
Current projects
Title |
Description |
AMYPAD
|
Amyloid imaging to prevent Alzheimer’s disease
- AMYPAD aims to determine the value of ß-amyloid imaging as a diagnostic & therapeutic marker for Alzheimer’s disease.
|
CHARIOT Pro |
Cognitive Health in Ageing Register: Investigational, Observational & Trial Studies in Dementia Research: Prospective Readiness Cohort Study
- Sub study to assess optimal measurement of cognition in amyloid positive patients, without dementia over 3.5 years.
|
CiBraT
|
Circadian Brain Temperature Study (Diurnal brain temperature mapping by Magnetic Resonance Spectroscopy (MRS) in healthy volunteers)
- Single-site study to determine how brain temperature varies by time of day in healthy adult men & women. Led by the MRC Laboratory of Molecular Biology, Cambridge, in collaboration with Edinburgh Imaging & the Centre for Clinical Brain Sciences. Co-sponsored by University of Edinburgh & NHS Lothian.
|
EPAD |
European Prevention of Alzheimer's Dementia
- Pan-European study led by University of Edinburgh to build a readiness & disease modelling cohort to feed & inform the design of a standing, Phase 2, proof-of-concept, adaptive clinical trial for the secondary prevention of Alzheimer’s dementia.
|
HARNESS
|
HARmoNising Brain Imaging MEthodS for VaScular Contributions to Neurodegeneration
- The objective of HARNESS is to disseminate &, where appropriate, standardise neuroimaging protocols for measuring the contributions of vascular disease to dementia & neurodegeneration.
|
LBC 1936
|
Lothian Birth Cohort 1936
- The Lothian Birth Cohorts of 1921 & 1936 are follow-up studies of the Scottish Mental Surveys of 1932 & 1947.
|
Neuro-Ret Biomarkers
|
- An international study led from Edinburgh & funded by ADDF
- Seeking to delivering novel neuro-retinal biomarkers for the early diagnosis of Alzheimer’s disease
|
PREVENT Dementia |
- A UK wide study led from Edinburgh
- Seeks to identify the biological & cognitive outcomes associated with neurodegenerative disease in mid-life (40-59) & develop better clinical & disease models of NDD in this very early pre-clinical population
|
R4VaD
|
Rates, Risks & Routes to Reduce Vascular Dementia
- Prospective clinical study evaluating the development of dementia among patients with stroke over at least 2 years.
|
UK DRI
|
UK Dementia Research Institute
- The UK DRI breaks new ground by bringing together world-leading expertise in biomedical, care & translational dementia research in a national institute.
|